Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,534 | 22,250 | 24,234 | 10,597 | 16,399 |
| Marketable Securities | 219 | 383 | N/A | N/A | N/A |
| Receivables | N/A | N/A | 50 | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 88 | 0 |
| TOTAL | $26,067 | $23,193 | $25,240 | $12,113 | $17,668 |
| Non-Current Assets | |||||
| PPE Net | 10 | 11 | 12 | 13 | 14 |
| TOTAL | $10 | $11 | $12 | $13 | $14 |
| Total Assets | $26,077 | $23,204 | $25,252 | $12,126 | $17,682 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 538 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,584 | 1,434 | 1,496 | 1,415 | 1,214 |
| Accrued Expenses | 1,733 | 1,204 | 1,203 | 895 | 1,971 |
| TOTAL | $3,855 | $2,638 | $2,699 | $2,310 | $3,185 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 27,964 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $27,964 |
| Total Liabilities | $3,855 | $2,638 | $2,699 | $2,310 | $31,149 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,990 | 17,300 | 16,897 | 12,564 | 10,930 |
| Common Shares | 2 | 2 | 2 | 1 | 1 |
| Retained earnings | -89,368 | -83,055 | -78,825 | -71,689 | -32,675 |
| TOTAL | $22,222 | $20,566 | $22,553 | $9,816 | $-13,467 |
| Total Liabilities And Equity | $26,077 | $23,204 | $25,252 | $12,126 | $17,682 |